CD34 and leukemia: The lack of miR-509 expression in healthy donor blood cell types and CD34+ HSPCs [32] exemplifies the importance of functional screening to identify growth-suppressing miRs, as expression profiling comparing acute leukemia cases versus healthy donor samples would not have identified miR-509 as a miR capable of inhibiting leukemia cell growth.